3 transcripts
NTRA
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
included input from experts in nephrology, clinical and lab genetics, kidney pathology and genetic counseling in addition to patients who also provided
NTRA
Earnings call transcript
NASDAQ
2023 Q4
28 Feb 24
being done in collaboration with the NCI funded Alliance Group. The lead PI of the study is Dr. Matthew Golsky, a leading expert in this space
NTRA
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
by medical experts in the field.
I'd like to spend a few minutes on the proactive data that was featured. As a reminder, ProActive is a large prospective
- Prev
- 1
- Next